United States Pharmaceuticals

Lycia Therapeutics Inc (LYCA)

Track

Track

Lycia Therapeutics, Inc. has recorded no insider trading activity within the previous ninety days. Consequently, there are no recent transactions to report regarding executive or director equity movements. The absence of market participation by corporate officers suggests a period of stability concerning internal share ownership levels.
Ticker: LYCA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Lycia Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-27 2026-10-27 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
35,291 +0.0%
244.46
US$4,600,285 		35,291 +0.0% 244.46 US$4,600,285
2026-10-27 2026-10-27 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
58,336 -12.0%
178.74
US$2,034,117 		58,336 -12.0% 178.74 US$2,034,117
2026-10-27 2026-10-26 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
9,034 +21.4%
363.32
US$1,346,204 		9,034 +21.4% 363.32 US$1,346,204
2026-10-27 2026-10-26 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
1,000 +40.2%
18.00
US$100,000 		1,000 +40.2% 18.00 US$100,000
2026-10-27 2026-10-23 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
1,000 +115.5%
26.11
US$100,000 		1,000 +115.5% 26.11 US$100,000
2026-10-27 2026-10-23 B Purchase
3.8
Venrock Healthcare Capital Partners III, L.P.
Large shareholder
1,000 +inf%
25.68
US$100,000 		1,000 +inf% 25.68 US$100,000
Explore more

More insider trading research around Lycia Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America